While efficacy is the main price mover, in my mind thats unlikely to be in under a year from the first dosing, and its only going to be in a few people, or potentially.
So that would be after August, and more likely it wont happen even this year.
And if it does it wont meet any statistical significance markers so they may not say much about it. Phase 2 and 3 are for that.
While efficacy is the main price mover, in my mind thats...
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.005(5.26%) |
Mkt cap ! $466.6M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $126.7K | 1.277M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10306 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 91480 | 2 |
View Market Depth
| Last trade - 16.10pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
9.9¢ |
Change
0.005 ( 4.21 %) |
||||
| Open | High | Low | Volume | ||
| 10.0¢ | 10.0¢ | 9.7¢ | 96942 | ||
| Last updated 15.25pm 14/05/2024 ? | |||||
| PYC (ASX) Chart |